Application Nr Approved Date Route Status External Links
NDA213973 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Qinlock Is Indicated For The Treatment Of Adult Patients With Advanced Gastrointestinal Stromal Tumor (Gist) Who Have Received Prior Treatment With 3 Or More Kinase Inhibitors, Including Imatinib. Qinlock Is A Kinase Inhibitor Indicated For The Treatment Of Adult Patients With Advanced Gastrointestinal Stromal Tumor (Gist) Who Have Received Prior Treatment With 3 Or More Kinase Inhibitors, Including Imatinib. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ripretinib

Comments